 Daily Health Report |
Genentech gets US hearing on Avastin, breast cancer
Reuters WASHINGTON, Feb 24 (Reuters) – Genentech has won a second chance to convince US regulators that its Avastin drug is a safe and effective treatment for breast cancer. The drugmaker, part of Roche Holding AG (ROG. … FDA Grants Hearing on Withdrawal of Bevacizumab Approval Prescriptions: F.D.A. Grants Hearing on Avastin as Treatment for Breast Cancer Genentech Gets FDA Hearing |
SanDisk 64GB Mobile Ultra MicroSDXC Class 10 UHS-1...
(806) 
182 days in the top 100 
485 days in the top 100 
(286) 
(2013) 
(407)
Comments on this entry are closed.